Stand aside — setup invalidated
Setup score 53, but distribution days reach 5 or more — stand aside until the condition resets.
Simple research view
DGX · Quest Diagnostics Incorporated
$231.14 -1.83% Sep 10 close
Switch to Advanced for indicator panels, raw grades, provenance, drawing tools, and full technical tables.
$DGX
Quest Diagnostics IncorporatedQuest Diagnostics Incorporated is a large-cap Services to the Health Industry company in the Health Services sector with a market cap of $26B.
Verdict · setup score 53/100 · data Sep 10 close · 1 session old
Stand aside — setup invalidated
Setup score 53, but distribution days reach 5 or more — stand aside until the condition resets.
Earnings
Normal technical setup
Next earnings
Monday, October 19, 2026
Before market open
Exact clock time not supplied by source
Deterministic evidence
DGX-1.83%
Sector proxy · XLV-0.55%
Broad market · SPY-0.60%
Session internals Weak
Rule: closed flat-to-down and in the bottom third of the range. Judged on internals, not on the size of the move.
Vs prior close-1.83%
From the open-2.19%
Range position32%
GapNo gap
QQQ confirmationConfirming (-1.06%)
SMH confirmationConfirming (-2.44%)
Ask a Legend to interpret this evidence → Commentary only — never scanner evidence or a sizing recommendation.
More stats
52W Low
$171.18
Tight Wks
0
Base
B1
SMA 200
$201.80
RS Line vs High
-5.4%
RS Line Slope
+0.5% ▲
Group Rank
#29/58
ADR%
2.0%
ATR(14)
$4.90 (2.1%)
Vol Pace (live)
N/A
U/D Vol
1.29
A/D Days
13A / 11D
A/D Rating
B
VDU Bars
0/10 d
Earnings
in 37d
DGX Chart
Interactive price, volume, RS, RSI, and MACD charts are available after sign in.
Technical Analysis Report Card
$DGX · $231.14 · as of 2026-09-10 · multi-factor read
55
/ 100
Reference read from price & volume only — the verdict at the top of the page decides the action.
Trend · Daily / Weekly / Monthly
Daily
▬ Sideways / consolidating
Weekly
▲ Uptrend
Monthly
▬ Sideways / consolidating
Moving Averages
50-day$228.89 ↑
100-day$212.68 ↑
200-day$201.80 ↑
Bullish (50 > 200)
RSI (14)
Reading41.4 · Bearish
Bearish momentum — sellers in control.
MACD (12/26/9)
StateWeakening
Histogram-1.982
Weakening — MACD slipped below its signal line. Histogram contracting.
Bollinger Bands (20,2)
%B / Width1% · 6.9%
Near the lower band — under pressure or oversold.
Volume · Buyer vs Seller
Up/Down vol1.29 · Neutral
Rel volume1.14×
Balanced — up/down volume is roughly even; no clear hand. Recent volume is easing versus its baseline.
Support & Resistance
R · $240.13swing level
R · $247.1952-week high
Price · $231.14now
S · $200.97swing level
S · $195.39swing level
S · $192.80swing level
Fibonacci · Uptrend swing
23.6% ◄ price here$232.80
38.2%$223.90
50.0%$216.71
61.8%$209.52
78.6%$199.28
Retracement support zones measured from the recent swing low up to the high.
The verdict is free. The trade plan is Pro.
Unlock the exact entry, stop-loss, profit target, and reward-to-risk for DGX — plus the full 500+ symbol scanner and Ask-the-Legends chat.
Start your 7-day free trial →
Weekly uptrendAbove 200-day MA50/200 bullish
Want this read in a legend's voice?
Ask a Legend about DGX
Generic technical analysis generated mechanically from price & volume — educational research only, not financial advice or a personalized recommendation. Levels are illustrative; confirm on your own chart. New to these terms? →
Legend Verdicts
6 methodology checks
Who would consider this setup, why it qualifies, and what blocks it — calculated from the same deterministic methodology rules used across Legend AI.
Council consensus:
5 of 6 legends are Watching — building, not yet a confirmed buy.
Watch
Minervini D
Trend-template read: 7/13 pass; wait for the soft misses to improve.
Passing evidence
1.1 Price > 150-day MA AND 200-day MAPrice $231.14, MA150 $208.46, MA200 $201.80
1.2 150-day MA > 200-day MAMA150 $208.46 vs MA200 $201.80
Failing evidence
1.8 RS rank ≥ 70 (prefer ≥ 85)RS rank 53
2. Quarterly EPS growth ≥ 25%+24.8% QoQ
Avoid
O'Neil D
CANSLIM read: fails C: Quarterly EPS acceleration ≥ 25%.
Passing evidence
N: Near 52-week high or RS line new high6.5% below high | RS line new high: False
S: Base tightness (ATR% ≤ 4.5%)ATR% 2.12%
Failing evidence
C: Quarterly EPS acceleration ≥ 25%+24.8% QoQ
L: RS rank ≥ 80 (IBD leadership)RS rank 53
Watch
Weinstein C
Stage-analysis read: Stage 2 is present; 2 supporting checks need improvement.
Passing evidence
Stage 2 (Advancing phase) confirmedStage 2 (Advancing)
Price above 30-week MA (200-day proxy)Price $231.14 vs MA200 $201.80
Failing evidence
Volume expansion above averageVolume ratio 1.14x
Relative strength ≥ 60RS 53
Watch
Livermore B
Pivotal-point read: constructive evidence is present, but relative strength is unresolved.
Passing evidence
Price$231.14
Distance from 52-week high6.5% below high
Failing evidence
Relative strengthRS 53
Volume vs average1.14x
Watch
Darvas B
Box-theory read: constructive evidence is present, but relative strength is unresolved.
Passing evidence
Price$231.14
Distance from 52-week high6.5% below high
Failing evidence
Relative strengthRS 53
Volume vs average1.14x
Watch
Wyckoff B
Supply-and-demand read: constructive evidence is present, but relative strength is unresolved.
Passing evidence
Price$231.14
Distance from 52-week high6.5% below high
Failing evidence
Relative strengthRS 53
Volume vs average1.14x
Base & Breakout
Breakout follow-through
No active breakout tracked — Legend AI monitors daily for pivot-point breaks. What's a breakout?
Latest candle: Bearish Engulfing — Today's down candle engulfs yesterday's up candle — a bearish reversal warning, most significant after an extended advance.
RS Line vs SPY
52-week relative strength · blue = RS line · dashed = MA50 · dot = NH
▲ Rising
Accumulation / Distribution
last 65 sessions · green = acc on high vol · red = dist on high vol
Net +3
Fundamentals & leadership quality — Minervini’s published criteria · 3/7 met
C
3/7 criteria
Separate score from the Minervini Trend Template (7/8): the Trend Template grades the price structure, this grades the company & leadership (earnings, sales, margins, RS rank). A stock can ride a clean trend while its fundamentals lag, so the two often differ by design — they are not the same checklist.
EPS acceleration ≥25% QoQ
+25%
Revenue growth ≥20% YoY
+12%
Gross margin ≥30%
33%
ROE ≥17%
14%
RS rating ≥80 (leadership)
53
Stage 2 uptrend (Weinstein)
Stage 2
Within 25% of 52W high
-6.5%
Method Playbook
Trade it like Minervini
EXACT LEVELS · PRO
Minervini D · Watch — The deterministic methodology check is Watch; wait for the failing or incomplete criteria to improve before the trigger can qualify.
Pivot
Pro levelPublished-method rule: Use the tight base's structural pivot; the setup must retain Trend Template leadership into the trigger.
Evidence: Canonical setup geometry is available with Pro.
Evidence: Canonical setup geometry is available with Pro.
Entry trigger
Pro levelPublished-method rule: Require a decisive move through the pivot with volume confirmation, and do not initiate more than 5% above it.
Evidence: Canonical setup geometry is available with Pro.
Evidence: Canonical setup geometry is available with Pro.
Initial stop
Pro levelPublished-method rule: Start at the tighter structural invalidation; the initial loss limit must not exceed roughly 7–8% from entry.
Evidence: Canonical setup geometry is available with Pro.
Evidence: Canonical setup geometry is available with Pro.
Trail
Rule-basedPublished-method rule: Hold the initial stop until the trade proves itself; near +1R move to breakeven, then trail a higher low or rising 10/21-day average once well extended.
Evidence: Planned management rule; no stored stop or broker order is changed automatically.
Evidence: Planned management rule; no stored stop or broker order is changed automatically.
Exit / invalidation
Pro levelPublished-method rule: Exit when the structural stop or a meaningful higher-low/short-term trend violation fires; never widen the stop.
Evidence: Canonical setup geometry is available with Pro.
Evidence: Canonical setup geometry is available with Pro.
Deterministic educational plan, not a recommendation. No order or stop is changed automatically. Method and sources →
The published-method workflow is public. Unlock exact pivot, entry, stop, target, and sizing with Pro →
Pattern Analysis
Wyckoff SOS
Historical replay: +20% before −8% within 40 sessions: 27% (n=71) · source bars 2025-03-17–2026-09-04 · avg +4.1% per setup (+0.52R)
⚠ Volatility widening into breakout
⚠ Extended past buy zone
⚠ Not actionable yet
53
setup score
RS Score
53
Trend template
7/8
CANSLIM
68.2* (B)
range low: 189.34
range high: 208.723
range pct: 0.102
sos thrust: 0.151
sos vol ratio: 1.5
sos bars ago: 7
near lps: ✗
validation reason: valid generic setup
multi tf evaluated: ✓
multi tf reason: weekly: MA stabilizing or rising — accumulation context supported
Why This Setup?
Wyckoff SOS · schematic
SOS: breakout above range_high=208.72, thrust=15.1%, vol=1.5x avg, lps=extended, 7 bars ago | Strong trend (7/8) | High-confidence pattern (70%) | Stage 2 | Readiness 57/100 (early) | CANSLIM 68.2 (B) | ⚠ Volatility widening into breakout; Extended past buy zone; Not actionable yet
The Universal Edge Check · context only
What the setup still has going for it, recorded for later. The verdict above stands — these principles do not overrule it.
2/7
universals met
- A relative-strength leader — not met RS rank 44 — laggard
- Risk is defined — not met No stop — undefined risk
- Asymmetric reward — partly met No target set
- Not chasing (in range) — partly met Pivot distance unknown
- Volume confirms — partly met 1.1× average — light
- Clear of earnings — met in 37 days
- In a confirmed uptrend — met Stage 2 · Trend template 7/8
Minervini Trend Template
7/8Grades the price structure — moving-average stacking, distance from the 52-week high/low, and relative strength above the ≥70 uptrend bar. This is the technical trend check; the company's fundamentals and ≥80 RS leadership are scored separately in the Grade Card.
Price above SMA 150 & 200
$231.14 vs SMA150 $208.46 / SMA200 $201.80
SMA 150 above SMA 200
SMA150 $208.46 vs SMA200 $201.80
SMA 200 trending up
Slope +5.74 over 20 days
SMA 50 above SMA 150 & 200
SMA50 $228.89
Price above SMA 50
$231.14 vs SMA50 $228.89
30%+ above 52-week low
+35.0% from $171.18
Within 25% of 52-week high
-6.5% from $247.19
RS score above 70
RS 53
Fundamentals
52W Range
79%
Mkt Cap SEC
25.5B
EPS QoQ
+25%
Rev YoY
+12%
ROE
14%
Gross Margin
33%
D/E
0.82
EPS TTM
$8.75
P/E TTM
26.4x
Float
110M
Company
Company profile
Quest Diagnostics Incorporated
CANSLIM — current EPS, annual EPS, new highs, supply, leader RS, inst. sponsorship, market
B
68.2* CANSLIM
* disqualified on C, M
C · Curr. EPS
92
A · Annual EPS
72
N · New Highs
100
S · Supply/Demand
100
L · Leader RS
53
I · Inst. Spons.
50
M · Market
30
Weekly Context
Multi-timeframe signals from weekly barsW. Trend
8/8
W. RS
78
W. Support
$186.23
W. Resist
$247.19
Weekly Structure
Trend
Neutral
Tight Weeks
0
Confirmation
Neutral
Scan History
20× streakSep 11
Wyckoff SOS
✓ Gate
53
Sep 11
Wyckoff SOS
✓ Gate
53
Sep 11
Wyckoff SOS
✓ Gate
53
Sep 11
Wyckoff SOS
✓ Gate
50
Sep 10
Wyckoff SOS
✓ Gate
54
0.0%
Sep 10
Wyckoff SOS
✓ Gate
53
0.0%
Get the full picture on DGX
Pro members see entry/stop/target levels, R:R ratios, intraday alerts, and every setup detected across 500+ symbols daily.
Start 7-Day Free Trial